Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GKT137831 in primary biliary cholangitis with elevated alkaline phosphatase
2016-004599-23Phase 2Completed
- Sponsor
- Genkyotex
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in primary biliary cholangitis (PBC) comparing GKT137831 + ursodeoxycholic acid with Placebo + ursodeoxycholic acid (2 arms). Started Apr 2017; status: completed.
02
Drugs
setanaxib
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on 2016-004599-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004599-23.